Liu Xueru, Zhang Juan, Yi Ting, Li Hui, Tang Xing, Liu Dan, Wu Daichao, Li Yukun
Department of Assisted Reproductive Centre, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, 412000, Hunan, China.
Department of Trauma Center, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, 412000, Hunan, China.
Biomark Res. 2025 Apr 18;13(1):62. doi: 10.1186/s40364-025-00779-x.
Angiogenesis, a crucial process in tumor growth and metastasis, necessitates targeted therapeutic intervention. This review reviews the latest knowledge of anti-angiogenesis targets in tumors, with emphasis on the molecular mechanisms and signaling pathways that regulate this process. We emphasize the tumor microenvironment's role in angiogenesis, examine endothelial cell metabolic changes, and evaluated potential therapeutic strategies targeting the tumor vascular system. At the same time, we analyzed the signaling pathway and molecular mechanism of tumor angiogenesis in detail. In addition, this paper also looks at the development trend of tumor anti-angiogenesis drugs, including their future development direction and challenges, aiming to provide prospective insight into the development of this field. Despite their potential, anti-angiogenic therapies encounter challenges like drug resistance and side effects, necessitating ongoing research to enhance cancer treatment strategies and the efficacy of these therapies.
血管生成是肿瘤生长和转移中的一个关键过程,需要进行靶向治疗干预。本综述回顾了肿瘤抗血管生成靶点的最新知识,重点关注调节这一过程的分子机制和信号通路。我们强调肿瘤微环境在血管生成中的作用,研究内皮细胞代谢变化,并评估针对肿瘤血管系统的潜在治疗策略。同时,我们详细分析了肿瘤血管生成的信号通路和分子机制。此外,本文还探讨了肿瘤抗血管生成药物的发展趋势,包括其未来的发展方向和挑战,旨在为该领域的发展提供前瞻性见解。尽管抗血管生成疗法具有潜力,但它们也面临着耐药性和副作用等挑战,因此需要持续开展研究以改进癌症治疗策略并提高这些疗法的疗效。